Tsukasa Oda1, Ruri Nakamura2, Tetsuhiro Kasamatsu2, Nanami Gotoh2, Hiroshi Handa3, Takayuki Saito2, Hirokazu Murakami2, Takayuki Yamashita1 (1.IMCR, Gunma University., Maebashi, Gunma, Japan, 2.Graduate School of Health Sciences, Gunma University, Gunma, Japan, 3.Dept. Hematology, Gunma University Graduate School of Medicine, Gunma, Japan)
Session information
Poster Session
Sat.Oct,12
Poster Session 2-21 Multiple Myeloma: Basic/Translational Research
Sat. Oct 12, 2019 5:40 PM - 6:20 PM Poster (Tokyo International Forum, B2F Hall E)
Chair: Akira Sakai (Dept. of Radiation Life Sciences, Fukushima Medical University School of Medicine)
Yoshiko Azuma, Tomoki Ito, Kai Imai, Minoru Shigesaka, Shosaku Nomura (Kansai Medical University, Hirakata City, Osaka, Japan)
Masanobu Sunaga1, Tsukasa Oda3, Eiko Yamane1, Rei Ishihara1, Yuki Murakami1, Saki Watanabe1, Yuta Asao1, Hisashi Takei2, Nobuhiko Kobayashi2, Yohei Osaki2, Morio Matsumoto4, Nanami Gotoh1, Tetsuhiro Kasamatsu1, Hiroaki Shimizu2, Takuma Ishizaki2, Hiromi Koiso2, Makiko Takizawa2, Hirono Iriuchishima2, Tomomi Sekigami5, Akihiko Yokohama5, Norifumi Tsukamoto6, Yuta Masuda1, Maaya Awata1, Kana Souma1, Nao Hashimoto1, Hirokazu Murakami7, Takayuki Saito1, Hiroshi Handa2 (1.Graduate School of Health Sciences, Gunma University, Gunma, Japan, 2.Department of Hematology, Gunma University, Gunma, Japan, 3.Institute of Molecular and Cellular Regulation, Gunma University, Gunma, Japan, 4.Hematology, National Hospital Organization Shibukawa Medical Center, Gunma, Japan, 5.Blood Transfusion Service, Gunma University Hospital, Gunma, Japan, 6.Oncology Center, Gunma University Hospital, Gunma, Japan, 7.Gunma University of Health and Welfare)
Eiko Yamane1, Tsukasa Oda3, Masanobu Sunaga1, Rei Ishihara1, Yuki Murakami1, Saki Watanabe1, Yuta Asao1, Hisashi Takei2, Nobuhiko Kobayashi2, Yohei Osaki2, Morio Matsumoto4, Nanami Gotoh1, Tetsuhiro Kasamatsu1, Hiroaki Shimizu2, Takuma Ishizaki2, Hiromi Koiso2, Makiko Takizawa2, Hirono Iriuchishima2, Tomomi Sekigami5, Akihiko Yokohama5, Norifumi Tsukamoto6, Yuta Masuda1, Maaya Awata1, Kana Souma1, Nao Hashimoto1, Hirokazu Murakami7, Takayuki Saito1, Hiroshi Handa2 (1.Graduate School of Health Science, Gunma University, Gunma, Japan, 2.Department of Hematology, Gunma University School of Medicine, Gunma, Japan, 3.Institute of Molecular and Cellular Regulation, Gunma, Japan, 4.National Hospital Organization Shibukawa Medical Center, Gunma, Japan, 5.Blood Transfusion Service, Gunma University Hospital, Gunma, Japan, 6.Oncology Center, Gunma University Hospital, Gunma, Japan, 7.Gunma University of Health and Welfare, Gunma, Japan)
Hiroki Tsuji, Takumi Futo, Koichi Samata, Tomofumi Yamamoto, Daiju Ichikawa, Maiko Matsushita, Yutaka Hattori (Graduate School of Pharmaceutical Sciences, Keio Univ., Tokyo, Japan)
Yuichi Nakamura, Tomoyuki Sakamoto, Itoko Okuda, Yu Akuzawa, Yoshihiro Ito, Naoki Wakimoto, Emi Kakegawa, Yumiko Uchida, Shigehisa Mori, Masami Bessho (Hematol., Saitama Medical Univ. Hosp., Saitama, Japan)
Rei Ishihara1, Tsukasa Oda3, Masanobu Sunaga1, Eiko Yamane1, Yuki Murakami1, Saki Watanabe1, Yuta Asao1, Hisashi Takei2, Nobuhiko Kobayashi2, Yohei Osaki2, Morio Matsumoto4, Nanami Gotoh1, Tetsuhiro Kasamatsu1, Hiroaki Shimizu2, Takuma Ishizaki2, Hiromi Koiso2, Makiko Takizawa2, Hirono Iriuchishima2, Tomomi Sekigami5, Akihiko Yokohama5, Norifumi Tsukamoto6, Yuta Masuda1,7, Maaya Awata1, Kana Souma1,2, Nao Hashimoto1, Hirokazu Murakami7, Takayuki Saito1,7, Hiroshi Handa1,2 (1.Gunma University Graduate School of Health Science, Gunma, Japan, 2.Department of Hematology, Gunma University School of Medicine, Gunma, Japan, 3.Institute of Molecular and Cellular Regulation, Gunma, Japan, 4.National Hospital Organization Shibukawa Medical Center, Gunma, Japan, 5.Blood Transfusion Service, Gunma University Hospital, Gunma, Japan, 6.Oncology Center, Gunma University Hospital, Gunma, Japan, 7.Gunma University of Health and Welfare)
[PS2-21-8] Predictive role of microRNA 193a-5p for transplant-eligible multiple myeloma: pilot study
Sung-Soo Park1,2, Tae Woo Kim1, Gi June Min1, Silvia Park1, Young-Woo Jeon3, Seung-Ah Yahng4, Seung-Hwan Shin5, Sung-Eun Lee1,2, Jae-Ho Yoon1,2, Byung-Sik Cho1,2, Ki-Seong Eom1,2, Yoo-Jin Kim1,2, Seok Lee1,2, Hee-Je Kim1,2, Seok-Goo Cho1, Jong Wook Lee1, Chang-Ki Min1,2 (1.Department of Hematology, Seoul St. Mary Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, 2.Leukemia Research Institute, The Catholic University of Korea, Seoul, Korea, 3.Department of Hematology, Yeoido St. Mary Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, 4.Department of Hematology, Incheon St. Mary Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea, 5.Department of Hematology, Eunpyeong St. Mary Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea)